ESMO Gastrointestinal Cancers Congress

The ESMO Gastrointestinal Cancers Congress 2026 will bring together leading experts in GI oncology from around the world for four days of scientific exchange, education, and collaboration. Held in Munich with virtual participation available, the congress serves as a major forum for advancing the understanding and management of gastrointestinal malignancies.

The programme will feature the latest developments in cancer prevention, diagnostics, precision medicine, and therapeutic innovation. Through expert-led sessions, multidisciplinary tumour board discussions, and presentations of new clinical research, participants will gain practical insights into current challenges and emerging opportunities across GI cancer care.

Key topics will include early detection strategies, biomarker-guided treatment approaches, advances in systemic therapies, and measures aimed at improving patient quality of life. The congress will also provide a platform for discussing real-world clinical experiences and exploring future directions in oncology practice.

Bringing together clinicians, researchers, and healthcare professionals, ESMO Gastrointestinal Cancers 2026 encourages international collaboration and knowledge sharing with the common goal of improving outcomes for patients affected by gastrointestinal cancers.

*Please note that medpresso.org is an independent entity and is not associated with the official organization of this event. Please refer to the official website through the provided link for additional information.